Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for Preserving Geriatric Muscle in Osteoporosis
NCT06118905Phase 4Recruiting
- Start
- Feb 2024
- Primary completion
- Feb 2029
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab in osteoporosis. Started Feb 2024; status: recruiting.
02
Drugs
denosumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT06118905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06118905.